Clinical Trials Directory

Trials / Completed

CompletedNCT02563509

Reconstitution of HIV-specific Immunity Against HIV

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Guangzhou 8th People's Hospital · Academic / Other
Sex
All
Age
16 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Research Goal: To reconstitute the anti-HIV specific immunity system of the AIDS patients, so the viruses could not massively replicate when HAART was discontinued, then make HIV functional cure possible.

Detailed description

The research aims at establishing a new treatment strategies of HIV. It will significantly improve the clinical therapy effects and effectively reduce the morbidity and mortality by reconstituting the immune systems of HIV infected patients and combining multiple therapy strategies. Therefore, the research could develop an cloning amplification system of immunocytes in vitro, and improve the antiviral immune system severely damaged before by transfusing the clone cells modified by specific HIV antigen. So HIV infected patients could discontinue the traditional anti-viral drug, but not develop opportunistic infections,which could obviously increase the life qualities of these patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALHIV-specific CD8 cellsBased on HAART, receive HIV-specific CD8 cells transfuion.

Timeline

Start date
2016-01-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2015-09-30
Last updated
2019-06-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02563509. Inclusion in this directory is not an endorsement.